CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Indivior Inc. v. Actavis Laboratories UT, Inc.

1:18-cv-00499

๐Ÿ“ก 5G SEP โ€ข ETSI Declared

Overview

Case Number 1:18-cv-00499
Filing Date 2018-04-04
Status Terminated
Termination Date 2019-09-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Actavis Laboratories UT, Inc. Operating Company

Represented By

4 Attorneys Listed

Stephen R. Smerek

UNDELIVERABLE EMAIL 2/26/2020

Michael K. Nutter

Email: mnutter@winston.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Indivior Inc. Operating Company

Represented By

7 Attorneys Listed

Timothy P. Heaton

UNDELIVERABLE EMAIL 6/1/20

Sujatha Vathyam

UNDELIVERABLE EMAIL 11/3/2020

Magnus J. Essunger

Email: magnus.essunger@troutman.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Gerald E. Porter

Email: gporter@orrick.com

Daniel Sharpe

Email: daniel.sharpe@troutman.com

Charanjit Brahma

Email: cbrahma@beneschlaw.com

Counter Defendant

Indivior UK Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Timothy P. Heaton

UNDELIVERABLE EMAIL 6/1/20

Sujatha Vathyam

UNDELIVERABLE EMAIL 11/3/2020

Magnus J. Essunger

Email: magnus.essunger@troutman.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Gerald E. Porter

Email: gporter@orrick.com

Daniel Sharpe

Email: daniel.sharpe@troutman.com

Charanjit Brahma

Email: cbrahma@beneschlaw.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 6 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (6 found):
PTAB: 6
USPTO PTAB Trial 2018-11-13
IPR2019-00328

Dr. Reddy's Laboratories S.A. et al. v. Indivior UK Limited et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2018-11-13
IPR2019-00329

Dr. Reddyโ€™s Laboratories S.A. et al. v. Indivior UK Limited et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2016-05-31
IPR2016-01113

Dr. Reddyโ€™s Laboratories, Inc. et al. v. Indivior UK Limited et al.

U.S. Continuation Sibling (8475832)
Status: Institution Denied
USPTO PTAB Trial 2015-12-03
IPR2016-00280

Teva Pharmaceuticals USA, Inc. v. Indivior UK Limited et al.

U.S. Continuation Sibling (8475832)
Status: Institution Denied
USPTO PTAB Trial 2014-06-20
IPR2014-00998

BioDelivery Sciences International, Inc. v. RB Pharmaceuticals Limited

U.S. Continuation Sibling (8475832)
Status: Institution Denied
USPTO PTAB Trial 2014-01-15
IPR2014-00325

BioDelivery Sciences International, Inc. v. RB Pharmaceuticals Limited

U.S. Continuation Sibling (8475832)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP โ€ข ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

โœ“ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
โœ“ Right to demand global FRAND portfolio determination.
โœ“ Non-discrimination defense: check licensing terms offered to competing implementers.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9687454
Sublingual and buccal film compositions
Filed: 2016-01-06
Issued: 2017-06-27
Active (9.1 yrs remaining)
Expires: 2036-01-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. ยง 283) Active Threat

Active Threat โ€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term โ€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. ยง 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

2

Granted

4

Denied

0

Pending / Review

0

Motions by Category

Motion to Transfer Venue (28 U.S.C. ยง 1404) 2 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. ยง 1404) Granted
Minute Entry for proceedings held before Judge Tena Campbell: Motion Hearing held on 3/13/2018 re 7 MOTION to Change Venue filed by Actavis Laboratories UT. Cou...
Entry #50 • 2018-03-13 Document →
Motion to Transfer Venue (28 U.S.C. ยง 1404) Granted
Stipulated MOTION for Extension of Time to Extend Briefing Schedule for Defendant's Motion to Transfer Venue and to Extend Deadlines for the Parties to Serve Ru...
Entry #13 • 2017-12-12 Document →
Procedural / Extension Motion Granted
Stipulated MOTION for Extension of Time Extend Date for Rule 26(f) Conference, Submission of Proposed Scheduling Order and Initial Pretrial Conference and Memor...
Entry #28 • 2017-12-19 Document →
Procedural / Extension Motion Granted
ORDER granting 13 Motion for Extension of Time to File Response/Reply re 7 MOTION to Change Venue and Memorandum in Support Replies due by 1/26/2018. Responses ...
Entry #14 • 2017-12-13 Document →

Docket Entries

(60 total)
Pleading / Complaint

Case has been indexed and assigned to Magistrate Judge Dustin B. Pead. Plaintiffs Indivior, Indivior UK Limited is directed to E-File the Complaint and cover sheet (found under Complaints and Other Initiating Documents) and pay the filing fee of $ 400.00 by the end of the business day.NOTE: The court will not have jurisdiction until the opening document is electronically filed and the filing fee paid in the CM/ECF system. Civil Summons may be issued electronically. Prepare the summons using the courts PDF version and email it to utdecf_clerk@utd.uscourts.gov for issuance. (tlh) [Transferred from Utah on 4/4/2018.] (Entered: 09/14/2017)

Entry #1 • 2017-09-14
1
Pleading / Complaint

COMPLAINT against Actavis Laboratories UT (Filing fee $ 400, receipt number 1088-2840945) filed by Indivior UK Limited, Indivior. (Attachments: # 1 Exhibit A - US9687454, # 2 Civil Cover Sheet Civil Coversheet) Assigned to Magistrate Judge Dustin B. Pead (Berger, Arthur) [Transferred from Utah on 4/4/2018.] (Entered: 09/14/2017)

Entry #2 • 2017-09-14
1

CORPORATE DISCLOSURE STATEMENT under FRCP 7.1 filed by Plaintiffs Indivior, Indivior UK Limited identifying P 1: Indivior Finance LLC; P 2: RBP Global Holdings Limited as Corporate Parent. (Berger, Arthur) [Transferred from Utah on 4/4/2018.] (Entered: 09/14/2017)

Entry #3 • 2017-09-14
1
Pleading / Complaint

WAIVER OF SERVICE Returned Executed filed by Actavis Laboratories UT as to Actavis Laboratories UT Waiver sent on 10/4/2017, answer due 12/4/2017. (Gehret, Michael) [Transferred from Utah on 4/4/2018.] (Entered: 10/18/2017)

Entry #4 • 2017-10-18
1
Pleading / Complaint

ANSWER to Complaint filed by Actavis Laboratories UT. Attorney Michael A. Gehret added to party Actavis Laboratories UT(pty:dft)(Gehret, Michael) [Transferred from Utah on 4/4/2018.] (Entered: 12/04/2017)

Entry #5 • 2017-12-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc